Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will showcase a new protective syringe label suitable for deep-freeze applications at PDA Universe of Pre-Filled Syringes & Injection Devices, October 17-18 in Gothenburg, Sweden. At Booth #135, Schreiner MediPharm will introduce its Freeze-Light-Protect syringe label, which combines light protection with viability at temperatures well below zero. The new solution is particularly relevant for sensitive mRNA-based substances as well as cell and gene therapies.
Therapies and vaccines with mRNA substances, as well as cell and gene therapies, are becoming increasingly prevalent. These novel active ingredients entail special logistical challenges. For starters, they must be transported and stored on dry ice at freezing temperatures as low as -100 °C. In addition, special light protection is frequently required, depending on the type of substance. Precisely for these applications, Schreiner MediPharm has developed the Freeze-Light-Protect syringe label.